Published Nov 10, 2026, 11:02 AM ET · Updated 3 days ago · 1 source

Harvard Bioscience outlines $3.8M-$4.2M Q4 adjusted EBITDA while Project Viking targets $3M 2027 savings

Seeking Alpha
Seeking Alpha
·
Original Report

Harvard Bioscience outlines $3.8M-$4.2M Q4 adjusted EBITDA while Project Viking targets $3M 2027 savings